Evidence map›Paper›PMID 29421563›Full record

ArticleBiomaterials2018

Lipophilic indocarbocyanine conjugates for efficient incorporation of enzymes, antibodies and small molecules into biological membranes.

Weston J Smith, Huy Tran, James I Griffin, Jessica Jones, Vivian P Vu, Lizanne Nilewski, Nathan Gianneschi, Dmitri Simberg

Abstract read
In one paragraph

Article in Biomaterials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Physicochemical and molecular determinants of lipid migration through multicellular assemblies.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Labeling of Erythrocytes by Porphyrin-Phospholipid.Advanced nanobiomed research · 2021
    Article
  9. Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Weston J SmithColorado Center for Nanomedicine and Nanosafety, University of Colorado Anschutz Medical Campus, Aurora, USA; Translational Bio-Nanosciences Laboratory, Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, USA.
Huy TranChemical and Biological Engineering Undergraduate Program, University of Colorado, Boulder, USA.
James I GriffinTranslational Bio-Nanosciences Laboratory, Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, USA.
Jessica JonesTranslational Bio-Nanosciences Laboratory, Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, USA.
Vivian P VuTranslational Bio-Nanosciences Laboratory, Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, USA.
Lizanne NilewskiDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, USA.
Nathan GianneschiDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, USA.
Dmitri SimbergColorado Center for Nanomedicine and Nanosafety, University of Colorado Anschutz Medical Campus, Aurora, USA; Translational Bio-Nanosciences Laboratory, Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, USA. Electronic address: dmitri.simberg@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of California, San Diego · USUniversity of Colorado Boulder · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Painted erythrocyte carriers for therapy of acute myeloid leukemiaR01CA194058 · NCI · UNIVERSITY OF COLORADO DENVER · PI SIMBERG, DMITRI · 2016 to 2020
$1.8M
The alternative complement pathway and hemocompatibility of nanosurfacesR01EB022040 · NIBIB · UNIVERSITY OF COLORADO DENVER · PI SIMBERG, DMITRI · 2016 to 2019
$1.4M
NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA194058NIBIB NIH HHS R01 EB022040
6 · The paper itself

Abstract

Decoration of cell membranes with biomolecules, targeting ligands and imaging agents is an emerging strategy to improve functionality of cell-based therapies. Compared to covalent chemistry or genetic expression on the cell surface, lipid painting (i.e., incorporation of lipid-conjugated molecules into the cell bilayer) is a fast, non-damaging and less expensive approach. Previous studies demonstrated excellent incorporation and retention of distearyl indocarbocyanine dye DiI in membranes of cells in vitro and in vivo. In order to exploit the membrane stability of DiI, we synthesized an amino-DiI derivative, to which we subsequently conjugated an antibody (cetuximab), an enzyme (superoxide dismutase), and a small molecule (DyLight 800). Red blood cells have long been used as drug delivery vehicles so they were utilized as a model to study the incorporation of DiI conjugates in the plasma membrane. All the DiI constructs demonstrated fast and efficient ex vivo incorporation in the membrane of mouse RBCs, resulting in millions of exogenous molecules per RBC. Following an intravenous injection into mice, the molecules were detected on circulating RBCs for several days. DiI anchored molecules showed longer residence time in blood and significantly higher area under the curve (AUC) compared to free non-conjugated molecules. Thus, cetuximab, SOD and DyLight painted on RBC showed 5.5-fold, 6.5-fold and 78-fold increase in the AUC, respectively, compared to the non-modified molecules. Lipophilic indocarbocyanine anchors are a promising technology for incorporation of biomolecules and small molecules into biological membranes for in vivo applications.

Indexed as

Cell MembraneCetuximabDrug Delivery SystemsErythrocytesLipid BilayersSuperoxide DismutaseCetuximabLipid BilayersSuperoxide DismutaseAntibodyDiIErythrocyteMembraneNear infrared fluorescencePaintingSOD

Identifiers

PMID29421563
PMCPMC6179438
OpenAlexW2791539051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.